Long
DopeCoin (DOPE) 2nd Entry (200%+ Profits Potential)
DopeCoin (DOPE) 2nd Entry by Alan Masters
DopeCoin (DOPE) charts signals are showing room for a second entry. Let's give it a try for an additional trade for this coin.
Looking at the daily chart, we have a very strong buy signal, coming from the 4+ month old bullish divergence on the MACD.
TRADE INSTRUCTIONS
Buy in: Up to 0.00000410
DopeCoin Targets:
SHORT TERM
(1) 517
(2) 619
(3) 783
(4) 900
Stop loss: 0.00000300
Capital allocation: Up to 2%.
Time: 2-4 weeks.
Thank you!
Namaste.
DopeCoin (DOPE) charts signals are showing room for a second entry. Let's give it a try for an additional trade for this coin.
Looking at the daily chart, we have a very strong buy signal, coming from the 4+ month old bullish divergence on the MACD.
TRADE INSTRUCTIONS
Buy in: Up to 0.00000410
DopeCoin Targets:
SHORT TERM
(1) 517
(2) 619
(3) 783
(4) 900
Stop loss: 0.00000300
Capital allocation: Up to 2%.
Time: 2-4 weeks.
Thank you!
Namaste.
Note
Strong bullish divergence on the MACD.DopeCoin (DOPE) will have its time soon...
Note
💥💥💥 Gain LIFETIME access for a one-time-payment 👉 lamatrades.com (Since 2017)
Results:
🥇XRP +2010%
🥇ADA +2216%
🥇TOSHI +1642%
🥇AVA +536%
🥇TRUMP +300%
t.me/anandatrades/971
🏆 More: t.me/alansantana1111/5935
Results:
🥇XRP +2010%
🥇ADA +2216%
🥇TOSHI +1642%
🥇AVA +536%
🥇TRUMP +300%
t.me/anandatrades/971
🏆 More: t.me/alansantana1111/5935
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
💥💥💥 Gain LIFETIME access for a one-time-payment 👉 lamatrades.com (Since 2017)
Results:
🥇XRP +2010%
🥇ADA +2216%
🥇TOSHI +1642%
🥇AVA +536%
🥇TRUMP +300%
t.me/anandatrades/971
🏆 More: t.me/alansantana1111/5935
Results:
🥇XRP +2010%
🥇ADA +2216%
🥇TOSHI +1642%
🥇AVA +536%
🥇TRUMP +300%
t.me/anandatrades/971
🏆 More: t.me/alansantana1111/5935
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.